Ask AI

From Target to Tolerability: Nurse-Led Strategies for Optimizing Bispecific Antibody Therapy in Multiple Myeloma

Gain expert insights into emerging efficacy and safety data on bispecific antibodies currently used to manage multiple myeloma to mitigate risk and improve patient outcomes through a ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

  • Live Event
    From Target to Tolerability: Nurse-Led Strategies for Optimizing Bispecific Antibody Therapy in Multiple Myeloma
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Optimizing Bispecifics in MM
From Target to Tolerability: Nurse-Led Strategies for Optimizing Bispecific Antibody Therapy in Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 05, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson